Big Dynorphin, a Prodynorphin-Derived Peptide Produces NMDA Receptor-Mediated Effects on Memory, Anxiolytic-Like and Locomotor Behavior in Mice
- 16 November 2005
- journal article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 31 (9) , 1928-1937
- https://doi.org/10.1038/sj.npp.1300959
Abstract
Effects of big dynorphin (Big Dyn), a prodynorphin-derived peptide consisting of dynorphin A (Dyn A) and dynorphin B (Dyn B) on memory function, anxiety, and locomotor activity were studied in mice and compared to those of Dyn A and Dyn B. All peptides administered i.c.v. increased step-through latency in the passive avoidance test with the maximum effective doses of 2.5, 0.005, and 0.7 nmol/animal, respectively. Effects of Big Dyn were inhibited by MK 801 (0.1 mg/kg), an NMDA ion-channel blocker whereas those of dynorphins A and B were blocked by the -opioid antagonist nor-binaltorphimine (6 mg/kg). Big Dyn (2.5 nmol) enhanced locomotor activity in the open field test and induced anxiolytic-like behavior both effects blocked by MK 801. No changes in locomotor activity and no signs of anxiolytic-like behavior were produced by dynorphins A and B. Big Dyn (2.5 nmol) increased time spent in the open branches of the elevated plus maze apparatus with no changes in general locomotion. Whereas dynorphins A and B (i.c.v., 0.05 and 7 nmol/animal, respectively) produced analgesia in the hot-plate test Big Dyn did not. Thus, Big Dyn differs from its fragments dynorphins A and B in its unique pattern of memory enhancing, locomotor- and anxiolytic-like effects that are sensitive to the NMDA receptor blockade. The findings suggest that Big Dyn has its own function in the brain different from those of the prodynorphin-derived peptides acting through -opioid receptors.Keywords
This publication has 53 references indexed in Scilit:
- Pronociceptive role of dynorphins in uninjured animals: N -ethylmaleimide-induced nociceptive behavior mediated through inhibition of dynorphin degradationPain, 2005
- Epilepsy, CNS viral injury and dynorphinTrends in Pharmacological Sciences, 2004
- No DREAM, No Pain: Closing the Spinal GateCell, 2002
- Modulation of the Behavioral and Neurochemical Effects of Psychostimulants by κ‐Opioid Receptor SystemsAnnals of the New York Academy of Sciences, 2001
- Drug AddictionsAnnals of the New York Academy of Sciences, 2001
- Morphometry of a peptidergic transmitter system: Dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizuresHippocampus, 1999
- Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous κ-opioid receptor agonistBritish Journal of Pharmacology, 1998
- 2-(3,4-Dichlorophenyl)-N-methyl-N-[(1S)-1-(3-isothiocyanatophenyl)-2-(1- pyrrolidinyl)ethyl]acetamide: An Opioid Receptor Affinity Label That Produces Selective and Long-Lasting .kappa. Antagonism in MiceJournal of Medicinal Chemistry, 1994
- Sites of analgesic action of dynorphinLife Sciences, 1983
- Dynorphin immunocytochemistry in the rat central nervous systemPeptides, 1982